Tag: Arcellx

Cell and Gene Therapy, Clinical Trials, Industry, Research and Development

Gilead buys into multiple myeloma cell therapy with Arcellx deal

December 9, 2022

Via: Biopharma Dive

Gilead placed a major bet on cell therapy with its $12 billion acquisition of Kite in 2017. To the frustration of some investors, the business took several years to ramp up. But sales have substantially grown in recent months. Gilead’s […]